Characterizing CAR Function Across Disease Indications to Enable Clinical Expansion

• Measuring CAR targeting and functional activity across diseases to understand indication-specific performance
• Comparing assay approaches assessing binding, functionality and cytotoxicity to ensure cross-indication characterization

Speakers:

Sam OHara

Director

Umoja Biopharma